What's Happening?
Recent advancements in cardiac repair and regenerative therapy have focused on the use of smart biomaterials that allow for spatiotemporally programmed therapeutic behavior. These materials are designed to be delivered and retained within the injured
heart, enhancing myocardial exposure and safety. Various delivery formats, such as systemic nanocarriers, injectable depots, and structured platforms, have been developed to translate material intelligence into effective cardiac engagement. Nanoparticles, particularly polymeric and lipid-based ones, are highlighted for their versatility in cardiac repair, offering scalable manufacture and compatibility with minimally invasive administration. These nanoparticles enable vascular transport, tissue penetration, and intracellular delivery, making them primary vehicles for deploying biomaterials within the injured heart. Additionally, cardiac patches and microneedle platforms provide durable, spatially confined therapeutic exposure by establishing direct physical contact with the injured tissue.
Why It's Important?
The development of smart biomaterials for cardiac repair is significant as it represents a shift towards more precise and effective treatment options for heart injuries. These advancements could potentially improve patient outcomes by enhancing the delivery and retention of therapeutic agents in the heart, reducing the need for invasive procedures, and minimizing side effects. The integration of these materials with minimally invasive techniques could also expand their applicability, making them accessible to a broader range of patients. Furthermore, the ability to program cardiac retention through nanocarrier composition and targeting strategies could lead to more personalized and effective treatments, ultimately improving the quality of life for individuals with cardiac conditions.
